Medicale Corp (MCLE) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerMedicale Corp (MCLE) trades at $0.0004. Sector: Consumer staples.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for MCLE: MCLE does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Medicale Corp (MCLE) Consumer Business Overview
Medicale Corp., a subsidiary of Magenta Acres Inc., is a pre-operational company in the consumer defensive sector, intending to enter the food distribution industry with dietary supplements and consulting services. Based in Wellington, Florida, the company currently lacks significant business activity and faces challenges in establishing its market presence.
What Is the Investment Thesis for MCLE?
Medicale Corp. presents a speculative investment opportunity due to its pre-operational status and lack of significant business activity as of March 18, 2026. The company's intention to distribute dietary supplements and offer consulting services in the consumer defensive sector is yet to be realized. Key value drivers would depend on successful market entry, establishing distribution channels, and building a customer base. Growth catalysts include effective execution of its business plan and leveraging the support of its parent company, Magenta Acres Inc. Potential risks include the competitive landscape of the food distribution and consulting sectors, the company's ability to secure funding, and the uncertainty of transitioning from a pre-operational state to a functioning business. Given the absence of financial data and operational metrics, assessing the company's intrinsic value is challenging.
Based on FMP financials and quantitative analysis
MCLE Key Highlights
Medicale Corp. was incorporated in 2020, indicating a relatively young company.
- The company is a subsidiary of Magenta Acres Inc., potentially providing access to resources and support.
- Medicale Corp. intends to operate in the consumer defensive sector, specifically targeting the food distribution industry.
- The company's business plan involves the distribution of dietary supplements and the provision of consulting services.
- As of 2026, Medicale Corp. does not have significant operations, indicating it is in the early stages of development.
Who Are MCLE's Competitors?
MCLE is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| HFFG HF Foods Group Inc. | $1.60 | -1.84% | $87.2M | 34 5-pillar |
| AVO Mission Produce, Inc. | $12.70 | -0.86% | $1.13B | 53 5-pillar |
| ANDE The Andersons, Inc. | $66.90 | -1.21% | $2.28B | 66 5-pillar |
| UNFI United Natural Foods, Inc. | $44.53 | -2.33% | $2.76B | 72 5-pillar |
| CHEF The Chefs' Warehouse, Inc. | $111.07 | -4.60% | $4.59B | 80 5-pillar |
| PFGC Performance Food Group Company | $92.58 | -1.35% | $14.7B | 63 5-pillar |
| USFD I am unable to provide a company dossier for USFD because there | $94.63 | -2.36% | $20.8B | 70 5-pillar |
| SYY Sysco Corporation | $76.38 | -1.43% | $36.5B | 70 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MCLE's Key Strengths?
Subsidiary of Magenta Acres Inc.
- Focus on the growing dietary supplements market.
- Intention to offer consulting services.
What Are MCLE's Weaknesses?
Pre-operational status with no significant business activity.
- Lack of established distribution channels.
- Limited brand recognition.
What Are the Key Risks for MCLE?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition in the dietary supplement market.
- Regulatory hurdles and compliance requirements.
- Economic downturn affecting consumer spending.
- Uncertainty of transitioning from pre-operational to operational status.
What Threats Does MCLE Face?
- Highly competitive food distribution and dietary supplement industry.
- Regulatory changes affecting the dietary supplement market.
- Economic downturn impacting consumer spending on non-essential goods.
What Are MCLE's Competitive Advantages?
- Potential access to resources and support from parent company, Magenta Acres Inc.
- Focus on the growing dietary supplements market.
- Intention to offer personalized consulting services for differentiation.
What Does MCLE Do?
Medicale Corp. was incorporated in 2020 and is based in Wellington, Florida. As a subsidiary of Magenta Acres Inc., Medicale Corp. intends to operate within the consumer defensive sector, specifically targeting the food distribution industry. The company's stated business plan involves the distribution of dietary supplements and the provision of consulting services. However, as of 2026, Medicale Corp. does not have significant operations, indicating that it is still in the initial stages of development and market entry. The company's focus on dietary supplements aligns with the broader health and wellness trend within the consumer market. The consulting services aspect suggests a potential diversification strategy, possibly aimed at providing expertise related to the dietary supplement industry or broader health and wellness topics. Given its current lack of operations, Medicale Corp.'s success will depend on its ability to effectively execute its business plan, establish distribution channels, and build a customer base. The backing of Magenta Acres Inc. could provide financial and strategic support, but the company will still need to navigate the competitive landscape of the food distribution and consulting sectors. The company's future trajectory remains uncertain, contingent on its ability to transition from a pre-operational state to a functioning business with revenue generation and market presence.
What Products and Services Does MCLE Offer?
- Intends to distribute dietary supplements.
- Plans to provide consulting services.
- Aims to operate in the consumer defensive sector.
- Targets the food distribution industry.
- Functions as a subsidiary of Magenta Acres Inc.
How Does MCLE Make Money?
- Distribute dietary supplements to consumers through various channels.
- Offer consulting services related to health and wellness.
- Generate revenue through the sale of dietary supplements and consulting fees.
What Industry Does MCLE Operate In?
Medicale Corp. intends to operate in the consumer defensive sector, specifically within the food distribution industry, focusing on dietary supplements. This sector is characterized by relatively stable demand, as consumers tend to maintain spending on essential goods and services regardless of economic conditions. The market for dietary supplements is growing, driven by increasing health awareness and an aging population. However, the industry is also highly competitive, with numerous established players and new entrants. Medicale Corp.'s success will depend on its ability to differentiate itself, establish effective distribution channels, and build brand recognition in a crowded market.
Who Are MCLE's Key Customers?
- Individuals seeking dietary supplements for health and wellness.
- Consumers interested in personalized consulting services.
- Retailers and distributors of dietary supplements.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Medicale Corp operates in the Food Distribution industry within the Consumer Defensive sector. It is headquartered in Wellington, US. The company is led by CEO Chen Zu De. MCLE has traded publicly since 2022.
Financial Health
Medicale Corp's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
MCLE Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
MCLE Latest News
No recent news available for MCLE.
MCLE Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for MCLE.
Price Targets
Wall Street price target analysis for MCLE.
MCLE MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for MCLE; grades run from A+ (80-100) to F (below 30).
MCLE OTC Market Information
MCLE trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
Medicale Corp Consumer Staples Stock: Key Questions Answered
What do analysts say about MCLE stock?
As of March 18, 2026, there is no available analyst coverage or consensus on Medicale Corp. (MCLE) stock. This is primarily due to the company's pre-operational status and lack of significant business activity.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is limited due to the company's pre-operational status.
- Financial data is unavailable.